News

pharmaphorum23h
Merck agrees $3.9 billion takeover of SpringWorks
Merck KGaA has reached an agreement with SpringWorks on a $47-per-share takeover deal that values the US biotech at $3.9 ...
Merck Cuts 2025 Outlook on Tariffs, Charges
Merck’s first-quarter net income increased as sales of its Keytruda cancer drug rose, but the Big Pharma company cut its 2025 ...
Merck posts higher profit, puts tariffs cost at $200 million
Merck on Thursday said its first-quarter adjusted profit rose 7% as lower costs helped offset a 2% decline in sales, ...
Merck lowers profit outlook, partly due to $200 million expected tariff hit
Merck said the expected tariff charge primarily reflects levies between the U.S. and China, but does not account for Trump’s ...
Why Merck, Black Hills, And Virtus Investment Partners Are Winners For Passive Income
Merck, Black Hills, and Virtus Investment Partners are good choices for investors seeking reliable passive income. Their ...
Seeking Alpha5d
MRK Merck & Co., Inc.
Merck & Co., Inc. operates as a healthcare company ... Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services ...
Morningstar5d
Merck absorbs $200 million in tariff costs into its earnings and full-year outlook
Merck said it still expects 2025 total sales ... We sell different types of products and services to both investment professionals and individual investors. These products and services are ...